Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery

被引:71
作者
Giovagnoli, Stefano [1 ]
Blasi, Paolo [1 ]
Schoubben, Aurelie [1 ]
Rossi, Carlo [1 ]
Ricci, Maurizio [1 ]
机构
[1] Univ Perugia, Dept Chem & Technol Drugs, I-06123 Perugia, Italy
关键词
capreomycin sulfate; large porous microspheres; tuberculosis; RSM;
D O I
10.1016/j.ijpharm.2006.10.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to evaluate if a simple double-emulsion method could be used for developing a new formulation of large porous microspheres (MS) potentially useful for capreomycin sulfate (CS) pulmonary delivery. Poly (DL-lactide-co-glycolide) was used for MS preparation. A simple W/O/W double-emulsion/solvent evaporation preparation method was employed and MS were characterized by UV spectrophotometry, particle size, and scanning electron microscopy. A computer-generated response surface method (RSM) was employed to evaluate % drug content, volume mean diameter (VMD), and span upon variation of two numeric and two categorical factors. MS size distribution was found to be strongly affected by the homogenization method and the type of emulsifier employed. Mean diameters ranged from I to 20 mu m. The MS presented a proper morphology, with a highly porous interior and a rough surface. Peptide content ranged between I and 20%. The region of optimality was referred to as a low VMD and span values, and a high drug content. The best results were found when using a 20% loading, 19.8-3.2 dichloromethane/acetone ratio, ultraturrax mixing, and HPMC as emulsifier. The double-emulsion method allowed the preparation of CS loaded large porous MS having suitable characteristics to match respirability requirements. The use of RSM helped to establish the conditions to obtain formulations potentially useful for a possible CS pulmonary delivery, by using a simple preparation method with a consistent time, cost, and material saving. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 28 条
[1]  
ABDELLAZIZ BJ, 1999, PHARM RES, V16, P555
[2]  
BRAIN JD, 1979, AM REV RESPIR DIS, V120, P1325
[3]   DRUG-DELIVERY VIA THE RESPIRATORY-TRACT [J].
BYRON, PR ;
PATTON, JS .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1994, 7 (01) :49-75
[4]   Lung specific stealth liposomes: Stability, biodistribution and toxicity of liposomal antitubercular drugs in mice [J].
Deol, P ;
Khuller, GK .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1997, 1334 (2-3) :161-172
[5]   Recent advances in pulmonary drug delivery using large, porous inhaled particles [J].
Edwards, DA ;
Ben-Jebria, A ;
Langer, R .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 85 (02) :379-385
[6]   Large porous particles for pulmonary drug delivery [J].
Edwards, DA ;
Hanes, J ;
Caponetti, G ;
Hrkach, J ;
BenJebria, A ;
Eskew, ML ;
Mintzes, J ;
Deaver, D ;
Lotan, N ;
Langer, R .
SCIENCE, 1997, 276 (5320) :1868-1871
[7]   Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine [J].
Evora, C ;
Soriano, I ;
Rogers, RA ;
Shakesheff, KM ;
Hanes, J ;
Langer, R .
JOURNAL OF CONTROLLED RELEASE, 1998, 51 (2-3) :143-152
[8]   Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis [J].
Fattorini, L ;
Iona, E ;
Ricci, ML ;
Thoresen, OF ;
Orrù, G ;
Oggioni, MR ;
Tortoli, E ;
Piersimoni, C ;
Chiaradonna, P ;
Tronci, M ;
Pozzi, G ;
Orefici, G .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1999, 5 (04) :265-270
[9]  
Ferrarini PL, 1998, FARMACO, V53, P741
[10]   Spray-dried poly(D,L-Lactide) microspheres containing carboplatin for veterinary use: In vitro and in vivo studies [J].
Gavini, E ;
Manunta, L ;
Giua, S ;
Achenza, G ;
Giunchedi, P .
AAPS PHARMSCITECH, 2005, 6 (01) :E108-E114